These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4780857)

  • 1. [Discontinuous combination chemotherapy in extensive prostatic cancer].
    Chauvin HF
    J Urol Nephrol (Paris); 1973; 79(7):701-2. PubMed ID: 4780857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination chemotherapy using 5-fluorouracil, chromomycin A3 and prednisolone for solid tumors (author's transl)].
    Saito T; Wakui A; Yokoyama M; Himori T; Takahashi H
    Nihon Gan Chiryo Gakkai Shi; 1973 Dec; 8(4):336-51. PubMed ID: 4798945
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trial of combined intermittent chemotherapy in prostatic cancers. Estrogen resistant metastases].
    Chauvin HF
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):397-8. PubMed ID: 4807868
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
    Schmidt JD; Scott WW; Gibbons R; Johnson DE; Prout GR; Loening S; Soloway M; deKernion JB; Pontes JE; Slack NH; Murphy GP
    Cancer; 1980 Apr; 45(7 Suppl):1937-46. PubMed ID: 6445225
    [No Abstract]   [Full Text] [Related]  

  • 5. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of 5-fluorouracil combined with hormones in low dose as a basal treatment for prostatic carcinoma].
    Takeuchi H
    Hinyokika Kiyo; 1984 Nov; 30(11):1703-9. PubMed ID: 6099050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trial.
    Breul J; Jakse G; Forster G; Lampel A; Rohani A; Hartung R
    Eur Urol; 1997; 32(3):280-3. PubMed ID: 9358213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of solid tumors with N-1-(2'-tetrahydrofuryl)-5-fluorouracil (FT-207) alone and in combination: comparison of intravenous and oral administration].
    Saito T; Wakui A; Yokoyama M; Takahashi H; Takahashi K
    Nihon Gan Chiryo Gakkai Shi; 1974 Nov; 9(4):395-406. PubMed ID: 4476739
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary report.
    Logothetis CJ; von Eschenbach AC; Samuels ML; Trindade A; Johnson DE
    Cancer Treat Rep; 1982 Jan; 66(1):57-63. PubMed ID: 7053267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Marcrae KD
    Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of hormone-unresponsive prostatic cancer and its metastatic foci].
    Kotake T
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):387-96. PubMed ID: 6764105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple drug chemotherapy in treatment of prostate adenocarcinoma Nb Pr A.I.-III.
    Drago JR; Worgul TJ
    Invest Urol; 1981 Nov; 19(3):191-3. PubMed ID: 7298290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of etimizol on patients with prostate cancer].
    Tiktinskiĭ OL; Novikov IF
    Urol Nefrol (Mosk); 1974; (3):55-7. PubMed ID: 4446172
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytostatic therapy of prostatic carcinoma. Current status and personal results].
    Nagel R; Leistenschneider W
    Urologe A; 1983 Sep; 22 Suppl():304-9. PubMed ID: 6356555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy in metastatic breast cancer].
    Kuten A; Lev L; Mohaliver J; Robinson E
    Harefuah; 1981 Feb; 100(3):118-20. PubMed ID: 7262675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment for hormone-refractory or relapsing prostatic cancer].
    Hirao Y; Ozono S; Okajima E
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):418-26. PubMed ID: 8678492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.